Annie Talbot has over 15 years of experience in clinical research, ranging from clinical trials to field intervention studies. She has been a co-investigator on a number of phase III clinical trials for antiretroviral drugs in Quebec and under aa fellowship at Stanford University. She was the principal investigator for an epidemiological study in Rwanda published in 2013 in the AIDS Education Prevention Journal as well as a community intervention study that targeted alcohol and drug use among young Rwandans. Additionally, while at Stanford University, she was a co-investigator and lead author of an epidemiological study of drug resistance in HIV-infected, antiretroviral-experienced adults, published in Antimicrobial Agents and Chemotherapy in 2010. Since joining the CRCHUM, she has participated in clinical research projects on the treatment of addictions, including the Optima project and the Cannabidiol project.